A new test to quickly diagnose respiratory syncytial virus (RSV) in children.
Rapid Diagnostic Test for Respiratory Syncytial Virus by Digital Nanobubbles
This study is working on a fast and easy test to quickly find out if young children have respiratory syncytial virus (RSV), which can make them very sick, using new technology that helps doctors get results faster so they can start treatment sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-10829263 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid diagnostic test for respiratory syncytial virus (RSV), which is a leading cause of severe respiratory illness in young children. The approach utilizes innovative digital nanobubble technology to enhance the sensitivity of existing diagnostic methods, allowing for quicker and more accurate detection of RSV. By using antibody-conjugated gold nanoparticles, the test aims to identify RSV particles directly, improving the speed of diagnosis and enabling timely treatment. This could help reduce the spread of the virus in healthcare settings and ensure appropriate use of antiviral therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are suspected of having respiratory syncytial virus infections.
Not a fit: Patients who are older than 11 years or those who do not exhibit symptoms of respiratory infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate RSV diagnoses, improving treatment outcomes for affected children.
How similar studies have performed: Previous research has shown promise in developing rapid diagnostic tests for infectious diseases, suggesting that this innovative approach may also yield successful results.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Qin, Zhenpeng — University of Texas Dallas
- Study coordinator: Qin, Zhenpeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.